Zivo Bioscience Inc ZIVO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZIVO is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $8.00
- Day Range
- $7.30–8.00
- 52-Week Range
- $0.48–19.08
- Bid/Ask
- $6.55 / $8.25
- Market Cap
- $22.22 Mil
- Volume/Avg
- 770 / 1,707
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 488.97
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Companion Animal Food Ingredient, NDI (New Dietary Ingredient, and Skin Health.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 8
- Website
- https://www.zivobioscience.com
Valuation
|
Metric
|
ZIVO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 488.97 |
Price/Cash Flow | — |
Price/Earnings
ZIVO
Financial Strength
|
Metric
|
ZIVO
|
|---|---|
Quick Ratio | 0.10 |
Current Ratio | 0.15 |
Interest Coverage | −14.13 |
Quick Ratio
ZIVO
Profitability
|
Metric
|
ZIVO
|
|---|---|
Return on Assets (Normalized) | −521.96% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ZIVO
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jmzbnmryx | Zwr | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nnlzkwl | Cyszq | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Dbwrjqzr | Csjbrl | $99.5 Bil | |
MRNA
| Moderna Inc | Trjtsztdz | Jrrwt | $38.8 Bil | |
ARGX
| argenx SE ADR | Mrxgnzzfl | Rvq | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Dvqdxms | Zvv | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Kxbclkl | Bkjxv | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Hgtntwd | Gjlvmz | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vqgqhyscp | Qnjrg | $12.5 Bil | |
INCY
| Incyte Corp | Mqckxjjw | Lznnj | $11.6 Bil |